跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dopam - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dopam
Approved
STANDARD
Dopam
Sakar Healthcare Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2c0f6cb25d68d611
Company
Sakar Healthcare Ltd.
Type
Standard
Approval Details
Approval Id
2c0f6cb25d68d611
Drug Approval Philippines Name
Dopam
Product Name
Dopam
Registration Number
DRP-12001
Brand Name
Dopam
Generic Name
Dopamine Hydrochloride
Dosage Form
Solution for Reconstitution (I.V. Infusion)
Dosage Strength
40 mg/mL
Manufacturer
Sakar Healthcare Ltd.
Importer
Macropharma Corporation
Distributor
Macropharma Corporation
Issuance Date
27 May 2022
Expiry Date
27 May 2027
Pharmacologic Category
Adrenergic and Dopaminergic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2c0f6cb25d68d611
Type
Standard
Back to Philippines FDA Approvals